Accessibility Menu
 
TELA Bio logo

TELA Bio

(NASDAQ) TELA

Current Price$0.77
Market Cap$36.96M
Since IPO (2019)-94%
5 Year-94%
1 Year-44%
1 Month+16%

TELA Bio Financials at a Glance

Market Cap

$36.96M

Revenue (TTM)

$77.06M

Net Income (TTM)

$39.00M

EPS (TTM)

$-0.89

P/E Ratio

-0.94

Dividend

$0.00

Beta (Volatility)

0.74 (Low)

Price

$0.77

Volume

8,052

Open

$0.88

Previous Close

$0.77

Daily Range

$0.77 - $0.89

52-Week Range

$0.67 - $2.20

TELA News

No articles available.

TELA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About TELA Bio

Industry

Healthcare Equipment and Supplies

Employees

209

CEO

Antony Koblish

Headquarters

Malvern, PA 19355, US

TELA Financials

Key Financial Metrics (TTM)

Gross Margin

67%

Operating Margin

-46%

Net Income Margin

-51%

Return on Equity

-676%

Return on Capital

-79%

Return on Assets

-63%

Earnings Yield

-1.06%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$36.96M

Shares Outstanding

44.53M

Volume

8.05K

Short Interest

0.00%

Avg. Volume

162.15K

Financials (TTM)

Gross Profit

$46.49M

Operating Income

$34.12M

EBITDA

$31.68M

Operating Cash Flow

$41.59M

Capital Expenditure

$989.00K

Free Cash Flow

$42.58M

Cash & ST Invst.

$52.67M

Total Debt

$43.06M

TELA Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$20.69M

+9.1%

Gross Profit

$13.97M

+8.6%

Gross Margin

67.52%

N/A

Market Cap

$36.96M

N/A

Market Cap/Employee

$176.82K

N/A

Employees

209

N/A

Net Income

$8.60M

+17.1%

EBITDA

$7.15M

+18.4%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$12.30M

+49.2%

Accounts Receivable

$13.17M

+13.4%

Inventory

$11.56M

-15.0%

Long Term Debt

$41.49M

+1.3%

Short Term Debt

$521.00K

-6.8%

Return on Assets

-63.32%

N/A

Return on Invested Capital

-79.49%

N/A

Free Cash Flow

$5.93M

+34.9%

Operating Cash Flow

$5.72M

+36.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SPRBSpruce Biosciences, Inc.
$63.50+7.94%
NRXPNRx Pharmaceuticals, Inc.
$2.12+19.49%
COEPCoeptis Therapeutics, Inc.
$10.35-6.40%
ICCMIceCure Medical Ltd
$0.61-5.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.61+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.80-0.02%
IBRXImmunityBio
$7.41-0.21%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.02%

Questions About TELA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.